Opdivo (nivolumab) - Ono Pharmaceutical, BMS
docetaxel - Generic mfg.
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases (clinicaltrials.gov) - Oct 17, 2026 - P=N/A | N=810 | Active, not recruiting | Sponsor: Brigham and Women's Hospital | Trial primary completion date: Sep 2026 ➔ Mar 2027 
Trial primary completion date • Lung Cancer • Lung Non-Small Cell Squamous Cancer • Lung Non-Squamous Non-Small Cell Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07485166
 
Oct 17, 2026
 
Prev Next